pancanology.com
Understanding Pancreatic Cancer Blog - Page 2 of 3 - using information to our advantage
http://www.pancanology.com/page/2
Understanding Pancreatic Cancer Blog. Using information to our advantage. Phase 3 Metastatic Pancreatic Adenocarcinoma Clinical Trial Results. Metastatic pancreatic adenocarcinoma patients (PDAC) don’t have a lot of good options. In this post, I’ve summarize the completed chemotherapy-based phase III trials for metastatic patients, providing links to publications, outlining the survival statistics, and identifying key subgroups that may have benefited from the treatment. Key Points for Patients. A patien...
rapidcircle.com
Rapid Circle
http://www.rapidcircle.com/nl/author/mark-overdijk
Wij zijn gespecialiseerd in de Microsoft cloud;. Office365, Azure, Dynamics CRM. HEALTH PARTNER OF THE YEAR. Microsoft: ‘Rapid Circle is named winner for demonstrating. Excellence in innovation and implementation of customer solutions. Based on Microsoft technology.'. Rapid Circle helpt organisaties succesvol te zijn met cloudtechnologie. We bieden ondersteuning van strategie tot beheer, bij de techniek én de organisatieverandering. Mobiel en in de cloud. Een digitale werkplek in 5 stappen? Rapid Circle ...
rapidcircle.com
What we do - Rapid Circle
http://www.rapidcircle.com/what-we-do
What we can do for you. Since 2008, Rapid Circle has been supporting organisations with the innovation of collaboration and the digital workplace, with the transition to the cloud and with the improvement of service with Office 365, Microsoft Azure and CRM online. Mobile and Cloud are our guiding principles. We do this with over 80 employees in Amsterdam, Pune (India) and Melbourne. In which way does a switch fit with the organisation strategy? Which components do I need and which do I not need? Developi...
crl.berkeley.edu
UC Berkeley Cancer Research Lab » Berkeley leading the way on new approaches to cancer immunotherapy
http://crl.berkeley.edu/2015/03/30/berkeley-leading-the-way-on-new-approaches-to-cancer-immunotherapy
Meetings and Short Courses. Online scheduling and access to the facility. The Story of Yervoy (Ipilimumab). Berkeley leading the way on new approaches to cancer immunotherapy. March 30th, 2015. A newly announced biotech deal shows how basic research at UC Berkeley is leading to new therapeutic approaches for cancer. Novartis has just announced. A major $750M partnership with Berkeley-based Aduro BioTech. Journal of Experimental Medicine. Showing that delivery of CDNs into mouse cells activated the mouse ...
sitelicense.cambridgesoft.com
SciStore.Com Site Subscription Institutions
http://sitelicense.cambridgesoft.com/sitelicense_gallery.cfm?t=ALL
If your company, school or institution has purchased a Site Subscription, you may be able to receive a software or database subscription for free! The institutions listed below have Site Subscriptions. What is a Site Subscription? Click here to download using your. Website: http:/ dgmif.re.kr/. Location: Busan, South Korea. Click here to download using your A-tune Software AG. Website: http:/ www.a-tune.de/. Location: Darmstadt, Germany. Click here to download using your Aalto University. Location: TORON...
foresitecapitalmanagement.com
Foresite Capital
http://www.foresitecapitalmanagement.com/portfolio
Since inception in 2011, we have invested in and helped build transformative category-defining companies across the therapeutics, devices,. Diagnostics, and services sectors. AcelRx Pharmaceuticals, Inc. Aduro BioTech (Nasdaq: ADRO) is a clinical stage cancer immuno-oncology company focused on the development of first-in-class technology platforms and products designed to stimulate robust and durable immune responses against cancer. Its lead product candidate, CRS-207, is currently being developed fo...
pivotpark.org
De ondernemingen - Life Sciences Community Oss
http://www.pivotpark.org/nl/44/de-ondernemingen
Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...